Cargando…
Unearthing EGFR Mutations and the Rewards of Persistence in Precision Oncology: Breaching the 10-Year Survival Barrier in Metastatic NSCLC With Active Disease
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
American Society of Clinical Oncology
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6998025/ https://www.ncbi.nlm.nih.gov/pubmed/32031456 http://dx.doi.org/10.1200/JGO.19.00357 |
| _version_ | 1783493792782876672 |
|---|---|
| author | Singh, Pawan Kumar Kumar, Rajender Bal, Amanjit Gupta, Nalini Kapoor, Rakesh Prasad, Kuruswamy Thurai Singh, Navneet |
| author_facet | Singh, Pawan Kumar Kumar, Rajender Bal, Amanjit Gupta, Nalini Kapoor, Rakesh Prasad, Kuruswamy Thurai Singh, Navneet |
| author_sort | Singh, Pawan Kumar |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-6998025 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | American Society of Clinical Oncology |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-69980252020-02-11 Unearthing EGFR Mutations and the Rewards of Persistence in Precision Oncology: Breaching the 10-Year Survival Barrier in Metastatic NSCLC With Active Disease Singh, Pawan Kumar Kumar, Rajender Bal, Amanjit Gupta, Nalini Kapoor, Rakesh Prasad, Kuruswamy Thurai Singh, Navneet JCO Glob Oncol Case Reports American Society of Clinical Oncology 2020-01-31 /pmc/articles/PMC6998025/ /pubmed/32031456 http://dx.doi.org/10.1200/JGO.19.00357 Text en © 2020 by American Society of Clinical Oncology https://creativecommons.org/licenses/by/4.0/ Licensed under the Creative Commons Attribution 4.0 License |
| spellingShingle | Case Reports Singh, Pawan Kumar Kumar, Rajender Bal, Amanjit Gupta, Nalini Kapoor, Rakesh Prasad, Kuruswamy Thurai Singh, Navneet Unearthing EGFR Mutations and the Rewards of Persistence in Precision Oncology: Breaching the 10-Year Survival Barrier in Metastatic NSCLC With Active Disease |
| title | Unearthing EGFR Mutations and the Rewards of Persistence in Precision Oncology: Breaching the 10-Year Survival Barrier in Metastatic NSCLC With Active Disease |
| title_full | Unearthing EGFR Mutations and the Rewards of Persistence in Precision Oncology: Breaching the 10-Year Survival Barrier in Metastatic NSCLC With Active Disease |
| title_fullStr | Unearthing EGFR Mutations and the Rewards of Persistence in Precision Oncology: Breaching the 10-Year Survival Barrier in Metastatic NSCLC With Active Disease |
| title_full_unstemmed | Unearthing EGFR Mutations and the Rewards of Persistence in Precision Oncology: Breaching the 10-Year Survival Barrier in Metastatic NSCLC With Active Disease |
| title_short | Unearthing EGFR Mutations and the Rewards of Persistence in Precision Oncology: Breaching the 10-Year Survival Barrier in Metastatic NSCLC With Active Disease |
| title_sort | unearthing egfr mutations and the rewards of persistence in precision oncology: breaching the 10-year survival barrier in metastatic nsclc with active disease |
| topic | Case Reports |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6998025/ https://www.ncbi.nlm.nih.gov/pubmed/32031456 http://dx.doi.org/10.1200/JGO.19.00357 |
| work_keys_str_mv | AT singhpawankumar unearthingegfrmutationsandtherewardsofpersistenceinprecisiononcologybreachingthe10yearsurvivalbarrierinmetastaticnsclcwithactivedisease AT kumarrajender unearthingegfrmutationsandtherewardsofpersistenceinprecisiononcologybreachingthe10yearsurvivalbarrierinmetastaticnsclcwithactivedisease AT balamanjit unearthingegfrmutationsandtherewardsofpersistenceinprecisiononcologybreachingthe10yearsurvivalbarrierinmetastaticnsclcwithactivedisease AT guptanalini unearthingegfrmutationsandtherewardsofpersistenceinprecisiononcologybreachingthe10yearsurvivalbarrierinmetastaticnsclcwithactivedisease AT kapoorrakesh unearthingegfrmutationsandtherewardsofpersistenceinprecisiononcologybreachingthe10yearsurvivalbarrierinmetastaticnsclcwithactivedisease AT prasadkuruswamythurai unearthingegfrmutationsandtherewardsofpersistenceinprecisiononcologybreachingthe10yearsurvivalbarrierinmetastaticnsclcwithactivedisease AT singhnavneet unearthingegfrmutationsandtherewardsofpersistenceinprecisiononcologybreachingthe10yearsurvivalbarrierinmetastaticnsclcwithactivedisease |